Design Therapeutics leads way as 4 bio IPOs raise $641M for clinical research March 26, 2021 Auto Bot BioPharma, biopharma nl, biotech IPO, cancer drugs, Clinical Trials, Pharma, Rare diseases 0 Design Therapeutics raised $240 million in the biggest biotech IPO this week. One other rare disease drug developer went public along with two oncology biotechs as the IPO momentum continues.